Search by Drug Name or NDC
NDC 51672-2120-06 Triple Antibiotic 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g Details
Triple Antibiotic 400; 3.5; 5000 [iU]/g; mg/g; [iU]/g
Triple Antibiotic is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.
MedlinePlus Drug Summary
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
Related Packages: 51672-2120-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Neomycin, Polymyxin, and Bacitracin Topical
Product Information
| NDC | 51672-2120 |
|---|---|
| Product ID | 51672-2120_0d5c5ca2-8559-44b0-9319-3547eae6006d |
| Associated GPIs | 90109803104200 |
| GCN Sequence Number | 007694 |
| GCN Sequence Number Description | neomycin/bacitracin/polymyxinB OINT. (G) 3.5-400-5K TOPICAL |
| HIC3 | Q5W |
| HIC3 Description | TOPICAL ANTIBIOTICS |
| GCN | 85459 |
| HICL Sequence Number | 033356 |
| HICL Sequence Number Description | NEOMYCIN SULFATE/BACITRACIN ZINC/POLYMYXIN B |
| Brand/Generic | Brand |
| Proprietary Name | Triple Antibiotic |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bacitracin Zinc, Neomycin Sulfate, and Polymyxin B Sulfate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 400; 3.5; 5000 |
| Active Ingredient Units | [iU]/g; mg/g; [iU]/g |
| Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part333B |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 51672-2120-06 (51672212006)
| NDC Package Code | 51672-2120-6 |
|---|---|
| Billing NDC | 51672212006 |
| Package | 6 APPLICATOR in 1 CARTON (51672-2120-6) / .9 g in 1 APPLICATOR |
| Marketing Start Date | 2021-09-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL d77239e6-5e81-439a-b0cd-f8be59169442 Details
SPL UNCLASSIFIED SECTION
Warnings
Directions
Other information
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 28.4 g Tube Carton
INGREDIENTS AND APPEARANCE
| TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin sulfate, and polymyxin b sulfate ointment |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
Revised: 9/2021
Document Id: 0d5c5ca2-8559-44b0-9319-3547eae6006d
Set id: d77239e6-5e81-439a-b0cd-f8be59169442
Version: 3
Effective Time: 20210913